Does PLATINUM Cause Malignant neoplasm progression? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Malignant neoplasm progression have been filed in association with PLATINUM (Platinum metallicum). This represents 6.7% of all adverse event reports for PLATINUM.
22
Reports of Malignant neoplasm progression with PLATINUM
6.7%
of all PLATINUM reports
7
Deaths
6
Hospitalizations
How Dangerous Is Malignant neoplasm progression From PLATINUM?
Of the 22 reports, 7 (31.8%) resulted in death, 6 (27.3%) required hospitalization, and 2 (9.1%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PLATINUM. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does PLATINUM Cause?
Disease progression (43)
Off label use (29)
Fatigue (27)
Metabolic disorder (24)
Thrombocytopenia (24)
Pneumonitis (23)
Anaemia (22)
Neutropenia (22)
Blood lactate dehydrogenase increased (20)
Hepatitis b core antibody positive (15)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which PLATINUM Alternatives Have Lower Malignant neoplasm progression Risk?
PLATINUM vs PLAVIX
PLATINUM vs PLECANATIDE
PLATINUM vs PLERIXAFOR
PLATINUM vs PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE
PLATINUM vs PNEUMOCOCCAL 7-VALENT CONJUGATE VACCINE